Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial.
Maeda Y, Yoshimura K, Matsui H, Shindo Y, Tamesa T, Tokumitsu Y, Hashimoto N, Tokuhisa Y, Sakamoto K, Sakai K, Suehiro Y, Hinoda Y, Tamada K, Yoshino S, Hazama S, Oka M. Maeda Y, et al. Among authors: shindo y. Cancer Immunol Immunother. 2015 Aug;64(8):1047-56. doi: 10.1007/s00262-015-1709-1. Epub 2015 May 16. Cancer Immunol Immunother. 2015. PMID: 25982372 Free PMC article. Clinical Trial.
[A case report of a patient with overlap syndrome systemic lupus erythematosus( SLE) and polymyositis( PM)whose condition improved following treatment for coexisting descending colon cancer].
Kijima T, Kanekiyo S, Nakasuga C, Inoue Y, Shindo Y, Tsutsui M, Yoshino S, Kubo M, Yano M, Bimoto M, Kanda T, Hazama S, Oka M. Kijima T, et al. Among authors: shindo y. Gan To Kagaku Ryoho. 2013 Nov;40(12):1936-8. Gan To Kagaku Ryoho. 2013. PMID: 24393971 Japanese.
Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
Maeda N, Yoshimura K, Yamamoto S, Kuramasu A, Inoue M, Suzuki N, Watanabe Y, Maeda Y, Kamei R, Tsunedomi R, Shindo Y, Inui M, Tamada K, Yoshino S, Hazama S, Oka M. Maeda N, et al. Among authors: shindo y. Ann Surg Oncol. 2014 Dec;21 Suppl 4(Suppl 4):S546-54. doi: 10.1245/s10434-014-3564-2. Epub 2014 Feb 22. Ann Surg Oncol. 2014. PMID: 24562936 Free PMC article.
A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
Hazama S, Nakamura Y, Tanaka H, Hirakawa K, Tahara K, Shimizu R, Ozasa H, Etoh R, Sugiura F, Okuno K, Furuya T, Nishimura T, Sakata K, Yoshimatsu K, Takenouchi H, Tsunedomi R, Inoue Y, Kanekiyo S, Shindo Y, Suzuki N, Yoshino S, Shinozaki H, Kamiya A, Furukawa H, Yamanaka T, Fujita T, Kawakami Y, Oka M. Hazama S, et al. Among authors: shindo y. J Transl Med. 2014 Apr 30;12:108. doi: 10.1186/1479-5876-12-108. J Transl Med. 2014. PMID: 24884643 Free PMC article. Clinical Trial.
510 results